Analysis Of Prescription of National Formularium Medicines Based on The Adjustment of Restriction in Public Hospitals of Sawah Besar 2018

Kuncoro Adi Susanto; Maura Linda Sitanggang; Delina Hasan; Ida Chorida

doi:10.35814/jifi.v19i1.1056

Kuncoro Adi Susanto Universitas Pancasila
Maura Linda Sitanggang Universitas Pancasila
Delina Hasan Universitas Pancasila
Ida Chorida Universitas Pancasila

DOI: https://doi.org/10.35814/jifi.v19i1.1056

Abstract

Health services provided to the public in the implementation of the National Health Insurance (NHI) include
promotional, preventive, curative and rehabilitative. In supporting the implementation of NHI, it is necessary
to make eff orts to ensure the availability, aff ordability and accessibility of medicines through the application of the National Formulary (Fornas) as a reference in health services in all health facilities. The purpose of this study was to determine the percentage of prescription drugs in accordance with the National Formulary at Sawah Besar Hospital in 2018. The research design descriptive analysis and data collection was carried out retrospectively in the form of prescribing drugs and from the Hospital Management Information System and Patient Medical Record data. This research was conducted with a sample size of around 19.690 recipes and a length of 6 months of research from July 2018 to December 2018. From the results of the study pattern of prescription writing against the suitability of the National Formulary was 71.22%. Compatibility of 75% antihyperlipidemic drugs with atorvastatin as the drug with the most non-conformity of restrictions. The conformity of antihypertension drugs 54.11% with Valsatran as one of the inconsistencies in restriction and insulin drugs, 70.03% the antihyperglycemia drug restriction inconsistencies.

References

1. Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/422/2017 tentang Rencana Strategis
Kementerian Kesehatan Tahun 2015 – 2019. Jakarta: Kementerian Kesehatan RI. 2017.

2. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.02.02/MENKES/524/2015 Tentang
Pedoman Penyusunan dan Penerapan Formularium Nasional. 2015.

3. Kementerian Kesehatan Republik Indonesia. Laporan akuntabilitas kinerja 2017. Jakarta. Kemkes RI: 2017.

4. Winda Syahdu. Formularium Nasional dan e-catalog obat sebagai upaya pencegahan korupsi dalam tata
kelola obat Jaminan kesehatan nasional(JKN). Jakarta: Integritas; 2018, volume 4 nomor 2.

5. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/707/2018. Tentang
Perubahan atas Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/659/2017
tentang Formularium Nasional; 2019.

6. Anonim. Infodatin, Pusat data dan informasi Kementerian Kesehatan Republik Indonesia: 2018.

7. Kementerian Kesehatan RI. Undang- Undang Republik Indonesia Nomor 72 tahun 2016 tentang Standar
Pelayanan Kefarmasian. Jakarta: 2016.

8. Keputusan Menteri Kesehatan Republik Indonesia Nomor 129/Menkes/SK/II/2008 tentang Standar
Pelayanan Minimal di Rumah Sakit; 2008.

9. Tim biomedis Riset Kesehatan Dasar, Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. Laporan Riset Kesehatan dasar (Riskesdas) Bidang Biomedis. 2018.